Zydus Cadila receives USFDA approval for anti-hypertensive tablets
The US health regulator has given its approval to Zydus Cadila for marketing its anti-hypertensive olmesartan medoxomil tablets in the American market. Cadila Healthcare has...
Download Unicorn Signals App
Powered By EquityPandit
